| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 10/03/2006 | US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115740 Pyrimido compounds having antiproliferative activity |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115658 Compounds of formula I are hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp) inhibitors, and are useful in therapeutic and prophylactic treatment of persons infected with hepatitis C virus. |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | CA2352405C New diphenylurea derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 10/03/2006 | CA2167718C Synthesis of taxol and its derivatives |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | EP1286967B1 Cyclohexane derivatives and their use as therapeutic agents |
| 09/26/2006 | US7112687 Methods for obtaining paclitaxel from taxus plants |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/20/2006 | EP1702920A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP1353916B1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1275961C Photoactive dicyclic alcohol and its prepn, medicinal composition and use |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/14/2006 | US20060205958 Direct dianhydride synthesis |
| 09/14/2006 | US20060205783 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 09/13/2006 | EP1699780A1 Novel quinoline derivatives |
| 09/13/2006 | EP1699455A1 Heterocyclic aspartyl protease inhibitors |
| 09/13/2006 | EP1406869B1 Taxol enhancer compounds |
| 09/13/2006 | CN1832943A Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity |
| 09/12/2006 | US7105673 Cardioprotective phosphonates and malonates |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105187 Isolating taxane and derivatives from soil from which a living plant has grown |
| 09/12/2006 | US7105185 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | WO2006093823A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599987A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | CA2599808A1 2- [ isoquinolin-s - carbonyl ) amino] -propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7101867 Benzofuran derivatives, their production and use |
| 09/05/2006 | US7101595 Photo-curable fluorene derivative and composition containing the same |
| 08/31/2006 | WO2006062984A3 Inhibitors of protein kinases |
| 08/31/2006 | US20060194851 Benzofuran compound and medicinal composition containing the same |
| 08/31/2006 | US20060194834 Serotonin receptor antagonist; psychological disorders; Alzheimer's disease |
| 08/31/2006 | US20060194804 Hiv replication inhibiting pyrimidines and triazines |
| 08/31/2006 | US20060194778 Serotonin receptor antagonist; psychological disorders; side effect reduction |
| 08/30/2006 | EP1694641A2 Prostaglandin synthesis |
| 08/30/2006 | EP1487813B1 Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 08/30/2006 | CN1826331A Pi-3 kinase inhibitor prodrugs |
| 08/30/2006 | CN1826330A Combretastatin derivatives with cytotoxic action |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7097887 Liquid crystal compounds |
| 08/24/2006 | WO2006089060A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | WO2006087237A1 Purification of mupirocin |
| 08/24/2006 | WO2006070195A8 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 08/24/2006 | WO2006065686A3 Spiro derivatives as lipoxygenase inhibitors |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | CA2598897A1 Fungicidal pyrazine derivatives |
| 08/24/2006 | CA2598565A1 Purification of mupirocin |
| 08/23/2006 | EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists |
| 08/23/2006 | EP1692125A2 Irciniastatins a and b |
| 08/23/2006 | EP1692124A1 Biaryl sulfonamides as mmp inhibitors |
| 08/23/2006 | EP1691800A1 Methods and agents for inhibiting dynamin-dependent endocytosis |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | CN1823063A Quinoline derivatives as phosphodiesterase inhibitors |
| 08/23/2006 | CN1823059A Selective D1/dD receptor antagonists for the treatment of obesity and CNS disorders |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/22/2006 | US7094807 Viricides; hepatitis virus |
| 08/22/2006 | US7094805 Total synthesis of merrilactone A |
| 08/22/2006 | US7094803 Biologically active raspailamide compounds |
| 08/22/2006 | US7094781 Sulfamides and their use as endothelin receptor antagonists |
| 08/17/2006 | WO2006031782A3 Salvinorin derivatives as opioid receptor ligands |
| 08/16/2006 | EP1690862A1 Fatty acid monoesters of sorbityl furfural and relative compositions for cosmetic and dermatological use |
| 08/16/2006 | EP1689743A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 08/16/2006 | EP1689730A1 Gsk-3 inhibitors isolated from marine organisms |
| 08/16/2006 | EP1261603B1 Flavone derivatives, preparation method and use as medicines |
| 08/16/2006 | CN1820004A Benzofuran derivatives and their use in the treatment of microbial infections |
| 08/16/2006 | CN1269815C Novel process for preparation of silybum mariamum extractive methylglucamine |
| 08/16/2006 | CN1269811C Piperazine derivatives having SST1 antagonistic activity |
| 08/15/2006 | US7090953 Organophotoreceptor with a charge transport compound having an epoxy group |
| 08/15/2006 | CA2201219C Process for the preparation of substituted pyrimidines |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006062982A3 Urea inhibitors of map kinases |
| 08/10/2006 | US20060178369 Cinnamic acid amides |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | CA2589328A1 Multicyclic bis-amide mmp inhibitors |
| 08/09/2006 | EP1687289A1 Vitamin d receptor modulators |
| 08/09/2006 | EP1687277A1 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1814598A Valienamine A-4,7,4',7'-diacetal or ketone compound, and its preparation and use |
| 08/09/2006 | CN1814596A Muscarinic agonists |
| 08/08/2006 | US7087768 6-O-(4-methoxyaniline)acetyl fumagillol for example; superior angiogenesis inhibitory effect with less toxicity, also a cancer metastasis inhibitor, and treats angiogenesis related disorders such as other various inflammatory diseases such as rheumatic disease, psoriasis, and diabetic retinopathy |
| 08/08/2006 | US7087622 Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| 08/08/2006 | US7087603 Pyrazole compounds useful as protein kinase inhibitors |
| 08/03/2006 | WO2006080591A1 Fumagillol derivatives or method for preparation of fumagillol derivatives, and pharmaceutical compositions comprising the same |
| 08/03/2006 | WO2006065480A3 Tetrahydrocarbazoles as active agents for inhibiting vegf production by translational control |